DE69330514T2 - Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen - Google Patents

Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen

Info

Publication number
DE69330514T2
DE69330514T2 DE69330514T DE69330514T DE69330514T2 DE 69330514 T2 DE69330514 T2 DE 69330514T2 DE 69330514 T DE69330514 T DE 69330514T DE 69330514 T DE69330514 T DE 69330514T DE 69330514 T2 DE69330514 T2 DE 69330514T2
Authority
DE
Germany
Prior art keywords
inactivating
parasitaries
virals
bacterial blood
blood impurities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330514T
Other languages
English (en)
Other versions
DE69330514D1 (de
Inventor
P Goodrich
Nagendar Yerram
W Hackett
Marjan Van Borssum Waalkes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of DE69330514D1 publication Critical patent/DE69330514D1/de
Application granted granted Critical
Publication of DE69330514T2 publication Critical patent/DE69330514T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE69330514T 1992-01-27 1993-01-27 Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen Expired - Fee Related DE69330514T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82569192A 1992-01-27 1992-01-27
PCT/US1993/000401 WO1993014791A2 (en) 1992-01-27 1993-01-27 Method of inactivation of viral and bacterial blood contaminants

Publications (2)

Publication Number Publication Date
DE69330514D1 DE69330514D1 (de) 2001-09-06
DE69330514T2 true DE69330514T2 (de) 2002-03-28

Family

ID=25244689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330514T Expired - Fee Related DE69330514T2 (de) 1992-01-27 1993-01-27 Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen

Country Status (10)

Country Link
EP (1) EP0633786B1 (de)
JP (1) JP2001509773A (de)
AT (1) ATE203679T1 (de)
AU (1) AU3476593A (de)
CA (1) CA2128866A1 (de)
DE (1) DE69330514T2 (de)
IL (1) IL104530A0 (de)
NO (1) NO942781L (de)
WO (1) WO1993014791A2 (de)
ZA (1) ZA93587B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5578486A (en) * 1994-08-05 1996-11-26 International Tlb Research Institute, Inc. Recombinant microbial fertilizer and methods for its production
WO1996008965A1 (en) * 1994-09-22 1996-03-28 Baxter International, Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
AU698247B2 (en) * 1995-05-19 1998-10-29 New York Blood Center, Inc., The Methods of use of phthalocyanines to inactivate blood borne parasites
ATE300298T1 (de) * 1996-03-29 2005-08-15 Therakos Inc Behandlung von leukocyten durch photopheresis
AU714882B2 (en) 1996-04-09 2000-01-13 Therakos, Inc. Method for removal of psoralens from biological fluids
BR9807936A (pt) 1997-04-08 2000-02-22 Baxter Ag Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CN1230212C (zh) * 1997-07-10 2005-12-07 特拉科斯有限公司 肠和膀胱炎症紊乱的治疗
JP4643004B2 (ja) * 1998-01-06 2011-03-02 シーラス コーポレイション 生体材料中の病原体不活性化剤をクエンチするための方法
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2014194931A1 (en) 2013-06-03 2014-12-11 Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen Pathogen reduction treatment
US10449261B2 (en) 2014-07-24 2019-10-22 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
EP3634459A4 (de) 2017-02-10 2021-01-06 Washington University Antikörper gegen tip1 und verfahren zur verwendung davon
WO2021074970A1 (ja) * 2019-10-15 2021-04-22 株式会社日立ハイテク 核酸試料処理装置および核酸試料処理方法
GB2621757A (en) * 2021-06-14 2024-02-21 St Andrews Pharmaceutical Tech Limited Apparatus for improving hydration and / or reducing particle size of a product and a method of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
SU959786A1 (ru) * 1980-04-17 1982-09-23 Московский технологический институт мясной и молочной промышленности Способ консервировани цельной крови
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
EP0124363B1 (de) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemische Entkeimungsbehandlung von vollem Blut oder Blutbestandteilen
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
ATE232737T1 (de) * 1990-04-16 2003-03-15 Baxter Int Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
WO1993000005A1 (en) * 1991-06-21 1993-01-07 Baxter International Inc. Method for inactivating pathogens in a body fluid

Also Published As

Publication number Publication date
CA2128866A1 (en) 1993-08-05
WO1993014791A2 (en) 1993-08-05
DE69330514D1 (de) 2001-09-06
NO942781D0 (no) 1994-07-26
NO942781L (no) 1994-09-15
EP0633786B1 (de) 2001-08-01
EP0633786A4 (de) 1995-04-19
WO1993014791A3 (en) 2000-02-17
ZA93587B (en) 1994-07-07
EP0633786A1 (de) 1995-01-18
ATE203679T1 (de) 2001-08-15
JP2001509773A (ja) 2001-07-24
IL104530A0 (en) 1993-05-13
AU3476593A (en) 1993-09-01

Similar Documents

Publication Publication Date Title
DE69330514T2 (de) Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen
DE69133198T2 (de) Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
DE69328685T2 (de) Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
ATE80803T1 (de) Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
IT1195071B (it) Apparecchio e procedimento per analizzare la finitura di articoli trasparenti,in particolare contenitori di vetro
DE69424522D1 (de) Methode zur resuspendierung von zellreichen konzentraten
DE3381783D1 (de) Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen.
ATE160818T1 (de) Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
ATE273386T1 (de) Menschliches cyclin e
DE3786233T2 (de) Durchfluss-Zytometrieverfahren zum Klassifizieren von Leukozyten und dazu angewandte Reagenzien.
DE3783282D1 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
IT7925568A0 (it) Composizione adatta al controllo di tessuti e/o liquidi biologici emetodo impiegante la stessa.
DE58904683D1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
CA2056619A1 (en) Method of inactivation of viral and bacterial blood contaminants
DK479788D0 (da) Fremgangsmaade til maerkning af stoffer med technetium- eller rheniumisotoper samt de maerkede stoffers anvendelse
DE69530761D1 (de) Methode und poröser träger zur entfernung von verunreinigungen
NO168810C (no) Fremgangsmaate og innretning for oppredning av blandet avfall, som husholdningssoeppel eller fraksjoner derav, for gjenvinning av plastfoliematerialer
ATE2442T1 (de) Verfahren zur herstellung von interferon und dabei verwendete kulturmediumzusammensetzung.
DE3776170D1 (de) Quelle ultravioletter strahlen und verwendung derselben in verfahren mit photochemischer reaktion.
DE59107602D1 (de) Verfahren und Mittel zur Beseitigung von Trübungen in biologischen Flüssigkeiten
FI93696B (fi) Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi
DE3482308D1 (de) Verfahren zur radioaktiven markierung von blutzellen und zusammensetzungen dafuer.
DE69111637T2 (de) Verfahren zur Trennung und Konzentration von Phosphopeptiden.
ATE44128T1 (de) (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)oxyessigs|ure und deren salze zur verwendung als heilmittel und diese enthaltende pharmazeutische zusammensetzungen.
DE9301715U1 (de) Vorrichtung zur Reduzierung von Radikalen in biologischen Flüssigkeiten wie Blut, insbesondere Behälter, auch in Form von Beuteln, Schläuchen o.dgl. in denen Blut aufbewahrt oder bewegt wird

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee